AGA2118

· Angitia Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AGA2118, covering 2026-01-23 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) [Phase 2]